Percept Transitions in FOG and PD
NCT06848205
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this research is to examine the possible causes and signs of freezing of gait (FOG) secondary to Parkinson's disease (PD). To achieve this, the study will use the novel (on-label and FDA-approved) local field potential (LFP) measuring capability of the Medtronic Percept™ deep brain stimulation (DBS) system to compare oscillatory activity in people who have Parkinson's disease, with and without freezing of gait (FOG).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Freezing of Gait
- Parkinson Disease
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 21 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- University of Minnesota
- Last updated on ClinicalTrials.gov
- March 3, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Minnesota · 1
- University of Minnesota, Movement Disorders Lab · Minneapolis, MN
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.